Master in Oncology (Professional Degree)

Zhengzhou University (ZZU) is a major national university in central China formed by the merger of three institutions and supported jointly by Henan Province and the Ministry of Education. Covering a broad range of disciplines from science and engineering to medicine, humanities and management, ZZU combines strong research capacity with an emphasis on student development. As a Project 211 participant, the university attracts a diverse student body and sustains active academic programs for international learners.

The university comprises multiple campuses with extensive teaching and research facilities, more than 330 research institutes and a publishing arm. The School of International Education administers degree and non-degree pathways for around 1,300 overseas students from roughly 60 countries, offering guaranteed campus accommodation for new international fee-paying students and wired internet access across residences. Industry links and intercollegiate partnerships support internships and practical learning opportunities.

Located in Zhengzhou, a historical and transport hub in central China, ZZU gives students access to rich cultural heritage sites and growing economic activity. The university’s wide international collaborations and comprehensive program portfolio make it a practical choice for students seeking strong regional ties, varied academic options and supportive services for living and studying in China’s heartland.

The Master in Oncology at Zhengzhou University is a 3-year professional degree program taught in English. It's for students who want to help people with cancer.

The program covers subjects like cancer biology, radiation therapy, and chemotherapy. Students develop skills in patient care, research methods, and medical imaging. They also get hands-on experience in clinical settings.

Graduates can work as Oncologists, Cancer Researchers, Radiation Therapists, or Medical Imaging Specialists. They can find jobs in hospitals, research centers, or pharmaceutical companies.